Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Disease Area

Disease Area Analytical science

The Game Is Up

| Joanna Cummings

Thin layer chromatography and SERS track down Viagra in adulterated healthcare products.

Disease Area Public health

Getting the Vaccine Message Across

| Roisin McGuigan

Some common strategies to dispel vaccine myths may instead be making the situation worse.

Disease Area Diagnostics & prognostics

When Minutes Matter

| Michael Schubert

New tests can speed up the diagnosis of severe sepsis, ensuring patients get the right treatment.

Disease Area Diagnostics & prognostics

Good on Paper

| Andres W. Martinez

As we develop new POCTs for resource-limited settings, the humble sheet of paper has a lot to offer.

Disease Area Diagnostics & prognostics

Beating the Clock in Brain Injury

| Roisin McGuigan

Diagnosis and prognosis of brain injury can be complex – but is simple blood test on the horizon?

Disease Area Biomedical engineering

How to Disappear Completely

| Roisin McGuigan

Developing stents for coronary artery disease that don’t outstay their welcome.

Disease Area Drug discovery

Targeting Tuberculosis

| Santiago Ramón-García

Existing drugs can – and should – be repurposed to fight neglected diseases.

Disease Area Public health

Hurdles to HIV Survival

| Roisin McGuigan

Why are so many patients with HIV still dying too young?

Disease Area Biomedical engineering

Growing a Greener Heart

The answer to biomedically engineering cardiac scaffolds may lie with plants

Disease Area Biomedical engineering

Rescinding Antimicrobial Resistance

| William Aryitey

The drug resistance of "superbug" K. pneumoniae can be reversed by tapping into its genome

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register